Functional imaging for radiotherapy treatment planning: current status and future directions—a review

In recent years, radiotherapy (RT) has been subject to a number of technological innovations. Today, RT is extremely flexible, allowing irradiation of tumours with high doses, whilst also sparing normal tissues from doses. To make use of these additional degrees of freedom, integration of functional image information may play a key role (i) for better staging and tumour detection, (ii) for more accurate RT target volume delineation, (iii) to assess functional information about biological characteristics and individual radiation resistance and (iv) to apply personalized dose prescriptions. In this article, we discuss the current status and future directions of different clinically available functional imaging modalities; CT, MRI, positron emission tomography (PET) as well as the hybrid imaging techniques PET/CT and PET/MRI and their potential for individualized RT.

[1]  Andrea Schaefer,et al.  A contrast-oriented algorithm for FDG-PET-based delineation of tumour volumes for the radiotherapy of lung cancer: derivation from phantom measurements and validation in patient data , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[2]  Bernd J Pichler,et al.  Principles of PET/MR Imaging , 2014, The Journal of Nuclear Medicine.

[3]  Marc Kachelrieß,et al.  Dual energy CT: how well can pseudo-monochromatic imaging reduce metal artifacts? , 2015, Medical physics.

[4]  Hanwen Zhang,et al.  A Comparison of the Imaging Characteristics and Microregional Distribution of 4 Hypoxia PET Tracers , 2014, The Journal of Nuclear Medicine.

[5]  Eugene Wong,et al.  Dynamic contrast enhanced CT aiding gross tumor volume delineation of liver tumors: an interobserver variability study. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  W van Elmpt,et al.  Characterization of tumor heterogeneity using dynamic contrast enhanced CT and FDG-PET in non-small cell lung cancer. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  P. Lambin,et al.  Robust Radiomics Feature Quantification Using Semiautomatic Volumetric Segmentation , 2014, PloS one.

[8]  M. Philippens,et al.  Repeatability of diffusion‐weighted imaging in rectal cancer , 2014, Journal of magnetic resonance imaging : JMRI.

[9]  P. Lambin,et al.  Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach , 2014, Nature Communications.

[10]  H. Thoeny,et al.  Diffusion-weighted MR imaging including bi-exponential fitting for the detection of recurrent or residual tumour after (chemo)radiotherapy for laryngeal and hypopharyngeal cancers , 2013, European Radiology.

[11]  G. Reischl,et al.  PET Imaging of Prostate Cancer Xenografts with a Highly Specific Antibody against the Prostate-Specific Membrane Antigen , 2009, Journal of Nuclear Medicine.

[12]  L. H. Gray,et al.  The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. , 1953, The British journal of radiology.

[13]  David Binns,et al.  The use of fused PET/CT images for patient selection and radical radiotherapy target volume definition in patients with non-small cell lung cancer: results of a prospective study with mature survival data. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  Jan J W Lagendijk,et al.  MR guidance in radiotherapy , 2014, Physics in medicine and biology.

[15]  D. Knol,et al.  Predictive value of diffusion-weighted imaging without and with including contrast-enhanced magnetic resonance imaging in image analysis of head and neck squamous cell carcinoma. , 2015, European journal of radiology.

[16]  Michael Baumann,et al.  Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  A. Padhani,et al.  Diffusion MR imaging for monitoring of treatment response. , 2011, Magnetic resonance imaging clinics of North America.

[18]  B. van Calster,et al.  Integrating pretreatment diffusion weighted MRI into a multivariable prognostic model for head and neck squamous cell carcinoma. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  T. Johnson,et al.  Dual-energy CT: general principles. , 2012, AJR. American journal of roentgenology.

[20]  Jan-Jakob Sonke,et al.  The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  C. Faivre-Finn,et al.  Early reduction in tumour [18F]fluorothymidine (FLT) uptake in patients with non-small cell lung cancer (NSCLC) treated with radiotherapy alone , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[22]  Fréderic Duprez,et al.  Maximum tolerated dose in a phase I trial on adaptive dose painting by numbers for head and neck cancer. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  Paul Kinahan,et al.  Tumor delineation using PET in head and neck cancers: threshold contouring and lesion volumes. , 2006, Medical physics.

[24]  Daniela Thorwarth,et al.  Correlation between tumor oxygenation and 18F-fluoromisonidazole PET data simulated based on microvessel images , 2013, Acta oncologica.

[25]  F. V. Velden,et al.  Pharmacokinetic analysis of [18F]FAZA in non-small cell lung cancer patients , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[26]  J. Dai,et al.  Diffusion-weighted MRI in early assessment of tumour response to radiotherapy in high-risk prostate cancer. , 2014, The British journal of radiology.

[27]  J. Petersen,et al.  Imaging hypoxia to improve radiotherapy outcome , 2012, Nature Reviews Clinical Oncology.

[28]  R. Steenbakkers,et al.  PET-based analysis of tumor glucose metabolism and tumor hypoxia before and during anti-neoplastic treatment , 2015 .

[29]  Marit Holden,et al.  Hypoxia-induced gene expression in chemoradioresistant cervical cancer revealed by dynamic contrast-enhanced MRI. , 2012, Cancer research.

[30]  Wade P. Smith,et al.  Hypoxia imaging with [F-18] FMISO-PET in head and neck cancer: potential for guiding intensity modulated radiation therapy in overcoming hypoxia-induced treatment resistance. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[31]  Branislav Jeremic,et al.  L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy. , 2005, International journal of radiation oncology, biology, physics.

[32]  Uwe Haberkorn,et al.  Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[33]  A. Houweling,et al.  FDG-PET and diffusion-weighted MRI in head-and-neck cancer patients: implications for dose painting. , 2013, Radiotherapy and Oncology.

[34]  Frank Verhaegen,et al.  Tissue segmentation in Monte Carlo treatment planning: a simulation study using dual-energy CT images. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[35]  Konstantin Nikolaou,et al.  Metal artifact reduction by dual energy computed tomography using monoenergetic extrapolation , 2011, European Radiology.

[36]  Johan Trygg,et al.  ADC texture--an imaging biomarker for high-grade glioma? , 2014, Medical physics.

[37]  Jan-Jakob Sonke,et al.  Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer , 2013, BMC Cancer.

[38]  Philippe Lambin,et al.  Functional MRI for radiotherapy dose painting. , 2012, Magnetic resonance imaging.

[39]  J. Hoogduin,et al.  Diffusion weighted MRI in head-and-neck cancer: geometrical accuracy. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[40]  Ronald Boellaard,et al.  Impact of [18F]FDG PET imaging parameters on automatic tumour delineation: need for improved tumour delineation methodology , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[41]  T. Mikkelsen,et al.  DW-MRI as a Biomarker to Compare Therapeutic Outcomes in Radiotherapy Regimens Incorporating Temozolomide or Gemcitabine in Glioblastoma , 2012, PloS one.

[42]  Christophe Deroose,et al.  The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer , 2010, Acta oncologica.

[43]  U. A. van der Heide,et al.  The use of probability maps to deal with the uncertainties in prostate cancer delineation. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[44]  Daniela Thorwarth,et al.  Hypoxia dose painting by numbers: a planning study. , 2007, International journal of radiation oncology, biology, physics.

[45]  Jamal Zweit,et al.  An alternative approach to histopathological validation of PET imaging for radiation therapy image-guidance: a proof of concept. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[46]  R. Hicks,et al.  Role of FDG-PET/CT in staging and follow-up of head and neck squamous cell carcinoma. , 2011, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[47]  Ronald Boellaard,et al.  Parametric Methods for Quantification of 18F-FAZA Kinetics in Non–Small Cell Lung Cancer Patients , 2014, The Journal of Nuclear Medicine.

[48]  Rainer Raupach,et al.  Frequency split metal artifact reduction (FSMAR) in computed tomography. , 2012, Medical physics.

[49]  R. Modzelewski,et al.  Interobserver Agreement of Qualitative Analysis and Tumor Delineation of 18F-Fluoromisonidazole and 3′-Deoxy-3′-18F-Fluorothymidine PET Images in Lung Cancer , 2013, The Journal of Nuclear Medicine.

[50]  Edward Ashton,et al.  Dynamic Contrast-Enhanced Magnetic Resonance Imaging , 2012, Definitions.

[51]  Vincent Gregoire,et al.  Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription. , 2011, Seminars in radiation oncology.

[52]  Harald H Quick,et al.  Towards integration of PET/MR hybrid imaging into radiation therapy treatment planning. , 2014, Medical physics.

[53]  Isabelle Berry,et al.  Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study. , 2008, International journal of radiation oncology, biology, physics.

[54]  Daniela Thorwarth,et al.  Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer , 2005, BMC Cancer.

[55]  Daniela Thorwarth,et al.  Physical radiotherapy treatment planning based on functional PET/CT data. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[56]  M. Baumann,et al.  Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[57]  P. Lambin,et al.  A Comparative Study of the Hypoxia PET Tracers ( 18 F)HX4, ( 18 F)FAZA, and ( 18 F)FMISO in a , 2015 .

[58]  K. Togashi,et al.  Prediction of clinical outcome after stereotactic body radiotherapy for non-small cell lung cancer using diffusion-weighted MRI and (18)F-FDG PET. , 2014, European journal of radiology.

[59]  Pierre Vera,et al.  Delineation of small mobile tumours with FDG-PET/CT in comparison to pathology in breast cancer patients. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[60]  J. Wildberger,et al.  Extracting atomic numbers and electron densities from a dual source dual energy CT scanner: experiments and a simulation model. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[61]  Wiro J Niessen,et al.  Feasibility of multimodal deformable registration for head and neck tumor treatment planning. , 2014, International journal of radiation oncology, biology, physics.

[62]  L. H. Gray,et al.  The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy , 1955, British Journal of Cancer.

[63]  G. Andreisek,et al.  Metallic artefact reduction with monoenergetic dual-energy CT: systematic ex vivo evaluation of posterior spinal fusion implants from various vendors and different spine levels , 2012, European Radiology.

[64]  J. Steinbach,et al.  Two or four hour ( 18 F)FMISO-PET in HNSCC is the contrast best? , 2011 .

[65]  B. Hoeben,et al.  18F-FLT PET During Radiotherapy or Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma Is an Early Predictor of Outcome , 2013, The Journal of Nuclear Medicine.

[66]  P. Luijten,et al.  Simultaneous MRI diffusion and perfusion imaging for tumor delineation in prostate cancer patients. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[67]  Anne Bol,et al.  A gradient-based method for segmenting FDG-PET images: methodology and validation , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[68]  N. Schwenzer,et al.  A strategy for multimodal deformable image registration to integrate PET/MR into radiotherapy treatment planning , 2013, Acta oncologica.

[69]  Wouter van Elmpt,et al.  Impact of PET reconstruction algorithm and threshold on dose painting of non-small cell lung cancer. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[70]  Thomas Beyer,et al.  A combined PET/CT scanner: the path to true image fusion. , 2002, The British journal of radiology.

[71]  K. Murase,et al.  Radiotherapy treatment planning with contrast-enhanced computed tomography: feasibility of dual-energy virtual unenhanced imaging for improved dose calculations , 2014, Radiation oncology.

[72]  Heidi Lyng,et al.  Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[73]  Yue Cao,et al.  DCE-MRI defined subvolumes of a brain metastatic lesion by principle component analysis and fuzzy-c-means clustering for response assessment of radiation therapy. , 2013, Medical physics.

[74]  W. Oyen,et al.  Influence of experience and qualification on PET-based target volume delineation , 2014, Strahlentherapie und Onkologie.

[75]  T. Yen,et al.  Dynamic Contrast-Enhanced MR Imaging Predicts Local Control in Oropharyngeal or Hypopharyngeal Squamous Cell Carcinoma Treated with Chemoradiotherapy , 2013, PloS one.

[76]  Yun-bin Chen,et al.  Diffusion-weighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma. , 2014, Magnetic resonance imaging.

[77]  M Partridge,et al.  Advanced imaging applied to radiotherapy planning in head and neck cancer: a clinical review. , 2006, The British journal of radiology.

[78]  M. Reiser,et al.  Material differentiation by dual energy CT: initial experience , 2007, European Radiology.

[79]  John L. Humm,et al.  Pharmacokinetic Analysis of Hypoxia 18F-Fluoromisonidazole Dynamic PET in Head and Neck Cancer , 2010, Journal of Nuclear Medicine.

[80]  Daniela Thorwarth,et al.  Modelling and simulation of [18F]fluoromisonidazole dynamics based on histology-derived microvessel maps , 2011, Physics in medicine and biology.

[81]  P. Castaldi,et al.  Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy? , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[82]  Rajan Jain,et al.  Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications , 2013, NMR in biomedicine.

[83]  Kristin D. Brockway,et al.  What is the best way to contour lung tumors on PET scans? Multiobserver validation of a gradient-based method using a NSCLC digital PET phantom. , 2012, International journal of radiation oncology, biology, physics.

[84]  Søren M Bentzen,et al.  Theragnostic imaging for radiation oncology: dose-painting by numbers. , 2005, The Lancet. Oncology.

[85]  J. Tonn,et al.  FET-PET for malignant glioma treatment planning. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[86]  X Allen Li,et al.  Variability of target and normal structure delineation using multimodality imaging for radiation therapy of pancreatic cancer. , 2014, International journal of radiation oncology, biology, physics.

[87]  Kari Tanderup,et al.  Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer , 2013, Acta oncologica.

[88]  E Spezi,et al.  Evaluation of advanced automatic PET segmentation methods using nonspherical thin-wall inserts. , 2014, Medical physics.

[89]  Ronald Boellaard,et al.  Effects of Image Characteristics on Performance of Tumor Delineation Methods: A Test–Retest Assessment , 2011, The Journal of Nuclear Medicine.

[90]  Kari Tanderup,et al.  Tracer kinetic model selection for dynamic contrast-enhanced magnetic resonance imaging of locally advanced cervical cancer , 2014, Acta oncologica.

[91]  P. Lambin,et al.  A comparative study of the hypoxia PET tracers [¹⁸F]HX4, [¹⁸F]FAZA, and [¹⁸F]FMISO in a preclinical tumor model. , 2015, International journal of radiation oncology, biology, physics.

[92]  Peng Wang,et al.  An approach to identify, from DCE MRI, significant subvolumes of tumors related to outcomes in advanced head-and-neck cancer. , 2012, Medical physics.

[93]  P. Lambin,et al.  Hypoxia imaging with [¹⁸F]HX4 PET in NSCLC patients: defining optimal imaging parameters. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[94]  Daniela Thorwarth,et al.  Multi-modality functional image guided dose escalation in the presence of uncertainties. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[95]  Xiaodong Wu,et al.  Comparative study with new accuracy metrics for target volume contouring in PET image guided radiation therapy. , 2012, IEEE transactions on medical imaging.

[96]  Bernhard Sattler,et al.  PET/CT (and CT) instrumentation, image reconstruction and data transfer for radiotherapy planning. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[97]  R. Fisher,et al.  Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[98]  V. Grégoire,et al.  A prospective clinical study of 18 F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[99]  Sandra Nuyts,et al.  Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. , 2007, International journal of radiation oncology, biology, physics.

[100]  M. Mix,et al.  Exploratory geographical analysis of hypoxic subvolumes using 18F-MISO-PET imaging in patients with head and neck cancer in the course of primary chemoradiotherapy. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[101]  D. Heron,et al.  Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy , 2014, Radiation Oncology.

[102]  Steen Jakobsen,et al.  FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[103]  Shiva K Das,et al.  Combining multiple FDG-PET radiotherapy target segmentation methods to reduce the effect of variable performance of individual segmentation methods. , 2013, Medical physics.

[104]  T. Holland-Letz,et al.  Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[105]  C. Terhaard,et al.  Diffusion-weighted MR imaging in laryngeal and hypopharyngeal carcinoma: association between apparent diffusion coefficient and histologic findings. , 2014, Radiology.

[106]  Thomas Filleron,et al.  Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme. , 2014, International journal of radiation oncology, biology, physics.

[107]  Christian Roux,et al.  A Fuzzy Locally Adaptive Bayesian Segmentation Approach for Volume Determination in PET , 2009, IEEE Transactions on Medical Imaging.

[108]  Andre Dekker,et al.  Prognostic value of metabolic metrics extracted from baseline positron emission tomography images in non-small cell lung cancer , 2013, Acta oncologica.

[109]  V. Grégoire,et al.  Gradient-based delineation of the primary GTV on FDG-PET in non-small cell lung cancer: a comparison with threshold-based approaches, CT and surgical specimens. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[110]  David Jaffray,et al.  Automated voxel-based analysis of volumetric dynamic contrast-enhanced CT data improves measurement of serial changes in tumor vascular biomarkers. , 2015, International journal of radiation oncology, biology, physics.

[111]  Ursula Nestle,et al.  Biological imaging in radiation therapy: role of positron emission tomography , 2009, Physics in medicine and biology.

[112]  E. J. van der Jagt,et al.  Clinical validation of FDG-PET/CT in the radiation treatment planning for patients with oesophageal cancer. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[113]  P. Lambin,et al.  In Vivo Quantification of Hypoxic and Metabolic Status of NSCLC Tumors Using [18F]HX4 and [18F]FDG-PET/CT Imaging , 2014, Clinical Cancer Research.

[114]  W. V. van Elmpt,et al.  Imaging techniques for tumour delineation and heterogeneity quantification of lung cancer: overview of current possibilities. , 2014, Journal of thoracic disease.

[115]  Wim J. G. Oyen,et al.  Pathology-based validation of FDG PET segmentation tools for volume assessment of lymph node metastases from head and neck cancer , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[116]  Dimitris Visvikis,et al.  Accurate automatic delineation of heterogeneous functional volumes in positron emission tomography for oncology applications. , 2010, International journal of radiation oncology, biology, physics.

[117]  J. Overgaard,et al.  Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[118]  Johannes A Langendijk,et al.  PET Imaging of Tumor Hypoxia Using 18F-Fluoroazomycin Arabinoside in Stage III–IV Non–Small Cell Lung Cancer Patients , 2013, The Journal of Nuclear Medicine.

[119]  J. Steinbach,et al.  Two or four hour [18F]FMISO-PET in HNSCC , 2011, Nuklearmedizin.

[120]  M. Philippens,et al.  Dynamic contrast enhanced MR imaging for rectal cancer response assessment after neo‐adjuvant chemoradiation , 2015, Journal of magnetic resonance imaging : JMRI.